CAH Related Analyst Ratings
-
Cardinal Health (CAH) Needs CVS Renewal After Walgreen Loss - Analyst
-
JPMorgan Resumes Cardinal Health (CAH) at Overweight
-
ISI Group Downgrades Cardinal Health (CAH) to Buy
-
Citi Downgrades Cardinal Health (CAH) to Neutral
-
Lazard Capital Downgrades Cardinal Health (CAH) to Neutral
-
Burrill Maintains Positive Stance on Navidea Biopharmaceuticals (NAVB) on FDA Approval
-
Mizuho Securities Upgrades Cardinal Health (CAH) to Buy
-
ISI Group Upgrades Cardinal Health (CAH) to Overweight
-
William Blair Downgrades Cardinal Health (CAH) to Market Perform
-
ISI Group Starts Cardinal Health (CAH) at Market Weight
-
Mizuho Securities Starts Cardinal Health (CAH) at Neutral
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract
-
Auriga Maintains a 'Buy' on CareFusion (CFN); Selling Neurodiagnostic Division Creates Less ConFusion
-
Barclays on U.S. Health Care Distribution & Technology: Earnings Preview on ABC, MCK and CAH
-
Auriga Starts CareFusion (CFN) at Buy; More Care and Less "ConFusion"
-
Barclays on U.S. Health Care Distribution & Technology: VA Contract Announcement Could Be Early January; No Change in Our Expectations
-
Susquehanna Upgrades Cardinal Health (CAH) to Positive, Raises Price Target
-
Citi Upgrades Cardinal Health (CAH) to Buy
-
Barclays Maintains an 'Overweight' on Cardinal Health (CAH); 10-K Review; Slightly Lifting 2011 Estimates
-
Lazard Capital Upgrades Cardinal Health (CAH) to Buy
-
Barclays on U.S. Health Care Distribution & Technology: Pharmaceutical Supply Chain: Constructive Tone Confirmed with June Qtr Preview
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
UBS Maintains a 'Buy' on McKesson (MCK); Q4 Earnings Preview
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Management Keeps Bar Low; Can’t Ignore Trends
-
Barclays on U.S. Equity Quantitative Strategies: Market Commentary & Portfolio Rebalance
-
Argus Upgrades Cardinal Health (CAH) to Buy
-
Susquehanna Raises Estimates & Price Target on Cardinal Health (CAH), Maintains Neutral Rating
-
UBS on U.S. Healthcare Distribution: 2011 Outlook and Quarterly Preview
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Still The Cheapest Stock In Our Universe
-
Barclays maintains an 'Overweight' rating on Cardinal Health (CAH); 'Setting the Plate for 2011': Analyst Day Announcements Help 'De-Risk' FY
-
Cardinal Health (CAH) Shares Jumping as Deutsche Bank Upgrades to Buy
-
Baird Upgrades Cardinal Health (CAH) to Outperform
-
UBS Reiterates a 'Buy' on Cardinal Health (CAH); Q1: Drug Distribution to Offset Medical
-
UPDATE - UBS Downgrades Omnicare (OCR) to Neutral; Moving To The Sidelines Post +25% Rally
-
Leerink Swann Initiates Coverage on Cardinal Health (CAH); Obstacles Clearing, But Near-Term Headwinds Keep Us Cautious
-
Fitch Raises IDR on Cardinal Health (CAH) from BBB to BBB+
-
Barclays Maintains an 'Overweight' on Cardinal Health (CAH); 'Up or No?' Expectations Into Q4
-
Goldman Sachs Raises Targets On MCK, ABC, CAH
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Expect EPS Upside Near- & Long-Term
-
Goldman Sachs Downgrades Cardinal Health (CAH) to Neutral
-
Citi Assumes Coverage on Pharmacy Benefit Management & Distribution Stocks
-
Oppenheimer Upgrades Cardinal Health (CAH) to Outperform
-
Thomas Weisel Upgrades Cardinal Health (CAH) to Overweight
-
Raymond James Upgrades Cardinal Health (CAH) to Outperform
-
Morgan Stanley Initiates Coverage on Several Stocks in Biotechnology and Drugs Sector
-
UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
-
Jefferies & Co Downgrades Cardinal Health (CAH) to Hold
-
Raymond James Upgrades Cardinal Health (CAH) to Market Perform
-
Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
-
Deutsche Bank Downgrades Cardinal Health (CAH) to Hold; Consider AmerisourceBergen (ABC) Instead
Back to CAH Stock Lookup
